Fundz

Mati Therapeutics Inc. reported raising $50,000 in an initial SEC Form D filing, from an offering of $1.2 Million

PRIVATEOct 16, 2018$50K of $1.2M raised

Amount Raised

$50,000

$50,000 sold, per SEC Form D (first sale Oct 16, 2018)

Round Type

Pre-Seed

AustinBiotechnologyHealth CareMedicalTherapeutics

Quick answer

Mati Therapeutics raised $50,000 in a Pre-Seed round, dated October 16, 2018. Mati Therapeutics is based in Austin, Texas, United States.

How much did Mati Therapeutics raise?
Mati Therapeutics raised $50,000 in a Pre-Seed round on October 16, 2018.
What does Mati Therapeutics do?
Mati Therapeutics is an Austin-based company developing a non-invasive, sustained drug delivery platform to treat ocular diseases such as glaucoma.
Where is Mati Therapeutics based and how big is it?
Mati Therapeutics is based in Austin, Texas, United States. Fundz records about 5 employees.
Who are the decision-makers at Mati Therapeutics?
Fundz holds 2 contacts at Mati Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Mati Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Compugen raised $12M on October 16, 2018.
  • 4D Molecular Therapeutics raised $90M on September 11, 2018.
  • Otolith Labs raised $750K (Seed) on November 28, 2018.
  • GT Medical Technologies raised $5.6M on November 26, 2018.
  • Abcuro raised $8M on November 21, 2018.
  • Amylyx Pharmaceuticals raised $13M on November 20, 2018.

Who to call at Mati Therapeutics, and when

A new round usually means Mati Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mati Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mati Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mati Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mati Therapeutics

Location

101 Colorado Street

Austin, Texas, United States

About

Mati Therapeutics is an Austin-based company developing a non-invasive, sustained drug delivery platform to treat ocular diseases such as glaucoma. Its proprietary Evolute® Punctal Plug Delivery System provides continuous, automated medication delivery, improving patient outcomes and eliminating the need for eye drops. Founded by industry veterans from Allergan, AMO, Abbott Laboratories, and QLT Inc., Mati brings over a century of combined ophthalmic expertise to advancing sustained therapy solutions for eye care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mati Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsChris M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Mati Therapeutics's next move

See what Strategic adds

Mati Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.